UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

Gut, 2015-10, Vol.64 (10), p.1539-1545

2015

Volltextzugriff (PDF)

HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2

Clinical cancer research, 2017-08, Vol.23 (15), p.4323-4334

2017

Volltextzugriff (PDF)

Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy

Clinical gastroenterology and hepatology, 2014-09, Vol.12 (9), p.1474-1481.e2

2014

Volltextzugriff (PDF)

Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum

Journal of immunological methods, 2012-08, Vol.382 (1-2), p.177-188

2012

Volltextzugriff (PDF)

S804 Pilot Study to Assess Pharmacokinetic and Pharmacodynamic Markers Following Enema-Dosing With Adalimumab in Patients With Active Ulcerative Colitis (UC)

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e574-e574

2022

Volltextzugriff (PDF)

S1058 A Scintigraphic Study to Evaluate the Safety, Tolerability, and Functions of a Drug Delivery System (DDS) Device in Healthy Subjects in Fasted State

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e766-e767

2022

Volltextzugriff (PDF)

S1581 Development of Ex Vivo and In Vivo Models to Assess the Performance of an Oral Biotherapeutic Delivery System Capsule

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e1127-e1128

2022

Volltextzugriff (PDF)

S1566 Evaluation of the Pharmacokinetics of PGN-OB1 Following Oral Administration of an Oral Biotherapeutics Delivery System (OBDS) in Yucatan Swine

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e1118-e1118

2022

Volltextzugriff (PDF)

S1061 A Scintigraphic Study to Evaluate the Localization and Delivery Function of a Drug Delivery System (DDS) Device in Patients With Active Ulcerative Colitis (UC) in a Fasted State

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e768-e769

2022

Volltextzugriff (PDF)

Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients

Inflammatory bowel diseases, 2013-05, Vol.19 (6), p.1139-1148

2013

Volltextzugriff (PDF)

A novel class of polymeric fluorescent dyes assembled using a DNA synthesizer

PloS one, 2020-12, Vol.15 (12), p.e0243218-e0243218

2020

Volltextzugriff (PDF)

Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer

Science signaling, 2014-03, Vol.7 (318), p.ra29

2014

Volltextzugriff (PDF)

Serum and Colonic Mucosal Immune Markers in Irritable Bowel Syndrome

The American journal of gastroenterology, 2012-02, Vol.107 (2), p.262-272

2012

Volltextzugriff (PDF)

An In vivo Platform for Translational Drug Development in Pancreatic Cancer

Clinical cancer research, 2006-08, Vol.12 (15), p.4652-4661

2006

Volltextzugriff (PDF)

Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay

Journal of pharmaceutical and biomedical analysis, 2013-05, Vol.78-79, p.39-44

2013

Volltextzugriff (PDF)

A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease

Journal of Crohn's and colitis, 2015-12, Vol.9 (12), p.1120-1126

2015

Volltextzugriff (PDF)

Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status

PloS one, 2014-08, Vol.9 (8), p.e103551-e103551

2014

Volltextzugriff (PDF)

A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers

PloS one, 2013-01, Vol.8 (1), p.e54644-e54644

2013

Volltextzugriff (PDF)

Tu1148 Mechanisms of Loss of Response to Adalimumab in Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-775-S-775

2013

Volltextzugriff (PDF)

Antibody response to infliximab and its impact on pharmacokinetics can be transient

The American journal of gastroenterology, 2013-06, Vol.108 (6), p.962-971

2013

Volltextzugriff (PDF)

Stratified Medicine: Maximizing Clinical Benefit by Biomarker-Driven Health Care

Nestle Nutrition Institute workshop series, 2016, Vol.84, p.91

Singh, Sharat

2016

Volltextzugriff (PDF)

Fr488 TARGETED DELIVERY OF SOLUBLE TOFACITINIB CITRATE TO THE SITE OF INFLAMMATION TO IMPROVE EFFICACY AND SAFETY

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-328-S-328

2021

Volltextzugriff (PDF)

Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients

Proteome science, 2011-12, Vol.9 (1), p.75-75, Article 75

2011

Volltextzugriff (PDF)

Determinants of duration of breastfeeding amongst women in Manipur

Bangladesh journal of medical science (Ibn Sina Trust), 2011, Vol.10 (4), p.235-239

2011

Volltextzugriff (PDF)

Postpartum Amenorrhoea among Manipuri Women: A Survival Analysis

Journal of health, population and nutrition, 2012-03, Vol.30 (1), p.93-98

2012

Volltextzugriff (PDF)

1 – 25 von 316

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(268)
Mit Volltextzugriff
(248)

Publikationsform

Sprache

Englisch
(314)
Sanskrit
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2

Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy

Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum

S804 Pilot Study to Assess Pharmacokinetic and Pharmacodynamic Markers Following Enema-Dosing With Adalimumab in Patients With Active Ulcerative Colitis (UC)

S1058 A Scintigraphic Study to Evaluate the Safety, Tolerability, and Functions of a Drug Delivery System (DDS) Device in Healthy Subjects in Fasted State

S1581 Development of Ex Vivo and In Vivo Models to Assess the Performance of an Oral Biotherapeutic Delivery System Capsule

S1566 Evaluation of the Pharmacokinetics of PGN-OB1 Following Oral Administration of an Oral Biotherapeutics Delivery System (OBDS) in Yucatan Swine

S1061 A Scintigraphic Study to Evaluate the Localization and Delivery Function of a Drug Delivery System (DDS) Device in Patients With Active Ulcerative Colitis (UC) in a Fasted State

Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients

A novel class of polymeric fluorescent dyes assembled using a DNA synthesizer

Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer

Serum and Colonic Mucosal Immune Markers in Irritable Bowel Syndrome

An In vivo Platform for Translational Drug Development in Pancreatic Cancer

Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay

A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease

Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status

A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers

Tu1148 Mechanisms of Loss of Response to Adalimumab in Crohn's Disease

Antibody response to infliximab and its impact on pharmacokinetics can be transient

Stratified Medicine: Maximizing Clinical Benefit by Biomarker-Driven Health Care

Fr488 TARGETED DELIVERY OF SOLUBLE TOFACITINIB CITRATE TO THE SITE OF INFLAMMATION TO IMPROVE EFFICACY AND SAFETY

Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients

Determinants of duration of breastfeeding amongst women in Manipur

Postpartum Amenorrhoea among Manipuri Women: A Survival Analysis

Suchergebnisse filtern